Compare Bristol-Myers Squibb Co (BMY) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Trip.com Group Ltd — how do they compare? Bristol-Myers Squibb Co trades at $63.5 (market cap $129.94B), while Trip.com Group Ltd trades at $46 (market cap $29.10B). The key difference: Bristol-Myers Squibb Co is far larger — about 4.5× Trip.com Group Ltd's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | TCOM | |
|---|---|---|
Market Cap | $129.94B | $29.10B |
Sector | Health | Consumer Cyclical |
52-Week High | $65.89 | $78.96 |
52-Week Low | $42.60 | $39.84 |
Enterprise Value | $163.92B | $21.75B |
Dividend Yield | 3.96% | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
